Deep Brain Stimulation for Morbid Obesity
common.study.values.description
“Deep Brain Stimulation for Morbid Obesity”
This is an open-label, phase I pilot trial designed to evaluate the safety and feasibility of deep brain stimulation (DBS) for the treatment of refractory morbid obesity. Patients with diagnoses of morbid obesity will be recruited and enrolled. All patients will receive DBS targeting two brains areas involved in the pathophysiology of obesity and will be followed post-operatively for 12 months.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-yes
Device - Deep Brain Stimulation
All patients will undergo surgical implantation of a deep brain stimulation (DBS) system, which involves placement of stimulating electrodes in the brain. These electrodes will be used to deliver electrical current to target two brain structures involved in the pathophysiology of obesity.
participant.views.study.view.additional
participant.views.study.view.scientific-title
Deep Brain Stimulation for the Treatment of Refractory Morbid Obesity
common.study.values.clinical-trial-id
NCT03650309
participant.views.study.view.id
aQWnLd
